Protocols, for prescribers.
Prescriber-facing summaries — dosing as reported in the literature, titration context, and the evidence behind it. Source-cited, independent, and never a substitute for clinical judgment.
These are editorial summaries of published dosing and evidence, for reference only. They don't constitute medical advice or a treatment protocol; prescribing decisions rest with the licensed clinician and the individual patient.
Today, the dosing lives on each peptide page.
Standardized, downloadable protocol packs are in preparation. In the meantime, the dosing references, titration context, and safety notes prescribers ask about already live on each peptide's reference page — source-cited and dated. Start from the library, or the category landings below.
Weight loss / GLP-1
Semaglutide, tirzepatide, retatrutide, liraglutide — dosing & titration references.
Open category →CategoryRecovery
BPC-157, TB-500 and the recovery set — what the evidence supports.
Open category →CategoryLongevity
Epitalon, thymalin, NAD+, MOTS-c — references and caveats.
Open category →Downloadable protocol packs
Standardized, prescriber-facing PDFs by category.
Coming soon